메뉴 건너뛰기
Psychopharmacology
Volumn 227, Issue 2, 2013, Pages 373-374
Optimising treatment of refractory schizophrenia
Author keywords

[No Author keywords available]
Indexed keywords

CLOZAPINE;
EID: 84879607748     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3076-y     Document Type: Letter
Times cited : (3)
References (8)
  • 1
    • 0034296570 scopus 로고    scopus 로고
    • Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns
    • 11013322 10.1176/appi.ps.51.10.1249 1:STN:280:DC%2BD3cvmslWmtA%3D%3D
    • Breier A, Buchanan R, Irish D, Carpenter W (2000) Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Psychiatr Serv 51(10):1249-1253
    • (2000) Psychiatr Serv , vol.51 , Issue.10 , pp. 1249-1253
    • Breier, A.1    Buchanan, R.2    Irish, D.3    Carpenter, W.4
  • 2
    • 84868591380 scopus 로고    scopus 로고
    • Dopamine synthesis capacity in patients with treatment-resistant schizophrenia
    • 23034655 10.1176/appi.ajp.2012.12010144
    • Demjaha A, Murray R, McGuire P, Kapur S, Howes OD (2012) Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry 169(11):1203-120
    • (2012) Am J Psychiatry , vol.169 , Issue.11 , pp. 1203-2120
    • Demjaha, A.1    Murray, R.2    McGuire, P.3    Kapur, S.4    Howes, O.D.5
  • 3
    • 0036898975 scopus 로고    scopus 로고
    • Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia
    • 12464462 10.1016/S0893-133X(02)00319-6 1:CAS:528:DC%2BD38XptFKisL8%3D
    • Fabrazzo M, La Pia S, Monteleone P, Esposito G, Pinto A, De Simone L, Bencivenga R, Maj M (2002) Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia. Neuropsychopharmacology 27(6):1050-1055
    • (2002) Neuropsychopharmacology , vol.27 , Issue.6 , pp. 1050-1055
    • Fabrazzo, M.1    La Pia, S.2    Monteleone, P.3    Esposito, G.4    Pinto, A.5    De Simone, L.6    Bencivenga, R.7    Maj, M.8
  • 4
    • 84870327506 scopus 로고    scopus 로고
    • Adherence to treatment guidelines in clinical practice: Study of antipsychotic treatment prior to clozapine initiation
    • 22955007 10.1192/bjp.bp.111.105833
    • Howes OD, Vergunst F, Gee S, McGuire P, Kapur S, Taylor D (2012) Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry 201(6):481-485
    • (2012) Br J Psychiatry , vol.201 , Issue.6 , pp. 481-485
    • Howes, O.D.1    Vergunst, F.2    Gee, S.3    McGuire, P.4    Kapur, S.5    Taylor, D.6
  • 5
    • 0028007550 scopus 로고
    • Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
    • 7977880 1:STN:280:DyaK2M%2FmvVGhsg%3D%3D
    • Lieberman J, Safferman A, Pollack S, Szymanski JC, Howard A, Kronig M, Bookstein P, Kane J (1994) Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 151(12):1744-1752
    • (1994) Am J Psychiatry , vol.151 , Issue.12 , pp. 1744-1752
    • Lieberman, J.1    Safferman, A.2    Pollack, S.3    Szymanski, J.C.4    Howard, A.5    Kronig, M.6    Bookstein, P.7    Kane, J.8
  • 7
    • 79957616685 scopus 로고    scopus 로고
    • NICE National Institute for Health and Clinical Excellence London
    • NICE (2009) NICE clinical guideline 82: schizophrenia. National Institute for Health and Clinical Excellence, London
    • (2009) NICE Clinical Guideline 82: Schizophrenia
  • 8
    • 84873733831 scopus 로고    scopus 로고
    • Clozapine and therapeutic drug monitoring: Is there sufficient evidence for an upper threshold?
    • 23179967 10.1007/s00213-012-2922-7 1:CAS:528:DC%2BC38XhslWrtrrK
    • Remington G, Agid O, Foussias G, Ferguson L, McDonald K, Powell V (2013) Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold? Psychopharmacology 225(3):505-518
    • (2013) Psychopharmacology , vol.225 , Issue.3 , pp. 505-518
    • Remington, G.1    Agid, O.2    Foussias, G.3    Ferguson, L.4    McDonald, K.5    Powell, V.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.